KDB Life Insurance put on sale in 5th attempt

2022. 11. 29. 09:54
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

이 기사는 언론사에 의해 수정되어 본문과 댓글 내용이 다를 수 있습니다.

KDB Life Insurance headquarters in Seoul [Courtesy of KDB Life Insurance]
KDB-Consus Value (KCV) Monday announced that it has commenced a process to sell its entire stake in KDB Life Insurance in a fifth attempt since 2014.

KCV is a private equity fund jointly established by state-owned KDB and Consus Asset Management to acquire the life insurer then held by cash-strapped Kumho Group in 2010.

KCV already named multiple advisors for the sale of KDB Life Insurance. Among the advisory group members, Samil PwC is a leading deal advisor with EY responsible for finance, Milliman for actuary and Lee & Ko for legal affairs.

KCV is seeking to sell its 92.7 percent holding in KDB Life Insurance, which is estimated at 500 billion to 600 billion won ($450 million), including new share offering.

KCV aims to select a preferred bidder by the first quarter of 2023 and close the deal by the following quarter.

This is the fifth attempt to sell KDB Life Insurance. The latest sale was attempted in December 2020 when KDB agreed to sell the stake to JC Partners for 200 billion won, subject to a condition of raising 350 billion won from third-party investors for new shares, apart from the acquisition of existing shares.

But the deal fell through as JC Partners was found to be not eligible for becoming a majority shareholder of KDB Life Insurance under current laws. In April, financial regulators designated MG Non-Life Insurance, whose majority shareholder is JC Partners, as an ailing financial institution. JC Partners is in a legal fight with regulators.

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?